CAR T-Cell Therapy: Optimizing Collaboration, Referral, Treatment, and Follow-up to Improve Outcomes

Gain expert insights into best practices in CAR T-cell therapy for patients with leukemia, lymphoma, and myeloma with this dynamic online educational program. Download slides with key data and watch an on-demand, expert-led Webcast.
Michael R. Bishop, MD
Jae H. Park, MD

Downloadable Slidesets

Download these slides from our live meeting series to review key strategies for integrating CAR T-cell therapy into community-based management of patients with hematologic malignancies.

Michael R. Bishop, MD Jae H. Park, MD Released: January 26, 2021

Download this short summary slideset of key takeaway points from a live presentation on integrating CAR T-cell therapy into community-based management of patients with hematologic malignancies.

Michael R. Bishop, MD Jae H. Park, MD Released: January 26, 2021
Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Bristol-Myers Squibb
Novartis Pharmaceuticals Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue